170 related articles for article (PubMed ID: 6895386)
1. Microsomal nitroreductase activity of rabbit kidney and bladder: implications in 5-nitrofuran-induced toxicity.
Zenser TV; Mattammal MB; Palmier MO; Davis BB
J Pharmacol Exp Ther; 1981 Dec; 219(3):735-40. PubMed ID: 6895386
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens.
Zenser TV; Palmier MO; Mattammal MB; Bolla RI; Davis BB
J Pharmacol Exp Ther; 1983 Oct; 227(1):139-43. PubMed ID: 6413679
[TBL] [Abstract][Full Text] [Related]
3. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
Cohen SM; Zenser TV; Murasaki G; Fukushima S; Mattammal MB; Rapp NS; Davis BB
Cancer Res; 1981 Sep; 41(9 Pt 1):3355-9. PubMed ID: 6790163
[TBL] [Abstract][Full Text] [Related]
4. Renal reduced nicotinamide adenine dinucleotide phosphate:cytochrome c reductase-mediated metabolism of the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide.
Mattammal MB; Zenser TV; Palmier MO; Davis BB
Cancer Res; 1985 Jan; 45(1):149-56. PubMed ID: 3917370
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide by prostaglandin endoperoxide synthetase.
Zenser TV; Mattammal MB; Davis BB
Cancer Res; 1980 Jan; 40(1):114-8. PubMed ID: 6765914
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin hydroperoxidase-mediated 2-amino-4-(5-nitro-2-furyl) [14C]thiazole metabolism and nucleic acid binding.
Mattammal MB; Zenser TV; Davis BB
Cancer Res; 1981 Dec; 41(12 Pt 1):4961-6. PubMed ID: 6796263
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase.
Wise RW; Zenser TV; Kadlubar FF; Davis BB
Cancer Res; 1984 May; 44(5):1893-7. PubMed ID: 6424934
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation of the bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in mice.
Swaminathan S; Bryan GT
Cancer Res; 1984 Jun; 44(6):2331-8. PubMed ID: 6722771
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer.
Dawley RM; Zenser TV; Mattammal MB; Lakshmi VM; Hsu FF; Davis BB
Cancer Res; 1991 Jan; 51(2):514-20. PubMed ID: 1898713
[TBL] [Abstract][Full Text] [Related]
10. Enhancing effect of allopurinol on the induction of bladder cancer in rats by n-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Wang CY; Hayashida S; Pamukcu AM; Bryan GT
Cancer Res; 1976 May; 36(5):1551-5. PubMed ID: 1268818
[TBL] [Abstract][Full Text] [Related]
11. Enhanced macromolecular binding of N-[4-(5-nitro-2-furyl)-2-thiazolyl]- formamide in germfree versus conventional rats.
Morton KC; Wang CY
Cancer Res; 1983 Aug; 43(8):3628-32. PubMed ID: 6190554
[TBL] [Abstract][Full Text] [Related]
12. Transport of the renal carcinogen 3-hydroxymethyl-1-([3-(5-nitro-2-furyl)allydidene]amino) hydantoin by renal cortex and cooxidative metabolism by prostaglandin endoperoxide synthetase.
Zenser TV; Balasubramanian TM; Mattammal MB; Davis BB
Cancer Res; 1981 Jun; 41(6):2032-7. PubMed ID: 6786731
[TBL] [Abstract][Full Text] [Related]
13. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
Cohen SM; Hasegawa R; Sakata T; Johansson SL
Cancer Res; 1989 Jan; 49(2):372-7. PubMed ID: 2491954
[TBL] [Abstract][Full Text] [Related]
14. Anaerobic metabolism and nuclear binding of the carcinogen 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT).
Mattammal MB; Zenser TV; Davis BB
Carcinogenesis; 1982; 3(11):1339-44. PubMed ID: 6817938
[TBL] [Abstract][Full Text] [Related]
15. Enhancement by phenothiazine and 2,5-di-O-acetyl-D-glucosaccharo-(1,4)(6,3)-dilactone of bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in rats.
Wang CY; Hayashida S
Cancer Lett; 1984 Aug; 24(1):37-43. PubMed ID: 6548659
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced carcinogenesis by urinary tract infection in rats.
Johansson SL; Anderström C; von Schultz L; Larsson P
Cancer Res; 1987 Jan; 47(2):559-62. PubMed ID: 3539325
[TBL] [Abstract][Full Text] [Related]
17. Nitroreductase-mediated metabolic activation of 2-amino-4-(5-nitro-2-furyl)thiazole and binding to nucleic acids and proteins.
Swaminathan S; Lower GM; Bryan GT
Cancer Res; 1982 Nov; 42(11):4479-84. PubMed ID: 6751523
[No Abstract] [Full Text] [Related]
18. Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat.
Spry LA; Zenser TV; Cohen SM; Davis BB
J Clin Invest; 1985 Sep; 76(3):1025-31. PubMed ID: 4044826
[TBL] [Abstract][Full Text] [Related]
19. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
Rice JR; Spry LA; Zenser TV; Davis BB
Cancer Res; 1988 Jan; 48(2):304-9. PubMed ID: 3121171
[TBL] [Abstract][Full Text] [Related]
20. 'Revised' mass spectral identification of 2-amino-4-(5-nitro-2-furyl)thiazole metabolites.
Mattammal MB; Lakshmi VM; Zenser TV; Davis BB; White E
Biomed Environ Mass Spectrom; 1988 May; 15(9):495-9. PubMed ID: 3382804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
